1. India Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Fischer Chemic Limited

Fischer Chemic Limited

FISCHER.BO
Fischer Chemic LimitedIN flagBombay Stock Exchange
32.90
INR
-1.50
- -
21.34BMarket Cap
Fischer Chemic Limited
FISCHER.BO
(Bombay Stock Exchange)

Recent

price

32.90

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
82.35
122.01
9.49
3.77
1.98
1.19
- -
- -
- -
- -
1.07
9.59
- -
10.44
18.86
0.76
2.32
Revenue per Share
-52.36
-18.13
-1.81
7.62
0.2
1.6
-0.19
-0.02
0.01
0.03
-0.24
8.17
-1.35
-2.12
1.65
0.01
0.12
Basic EPS, GAAP
-0.16
-7.11
1.97
7.31
-0.47
-0.44
-0.3
-0.02
-0.07
0.01
0.07
-3.33
-1.03
-8.48
-7.05
-0.64
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-36.22
-55.23
-8.78
-0.19
-1.32
-9.12
-1.08
-0.07
-1.88
-1.43
-1.67
-8.54
-2.21
-24.19
49.22
0.44
- -
Book Value per Share
-27.5
-45.63
-7.82
-0.19
-1.32
-0.16
-0.21
-0.03
-0.76
-0.56
-0.8
0.18
-1.33
-15.47
70.93
2.29
- -
Tangible Book Value per Share
- -
- -
2
2
- -
- -
2
34
1
2
2
- -
2
- -
11
1,452
535
Basic Weighted Avg Shares
14
21
16
6
- -
- -
- -
- -
- -
- -
2
2
- -
2
210
1,107
1,240
Sales/Revenue/Turnover
-61.7
-14.5
-35.27
-341.39
-141.43
134.53
- -
- -
- -
- -
-12.52
-10.67
- -
8.52
8
1.52
5.65
Operating Margin (%)
3
3
3
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
8
21
Depreciation Expense
-9
-3
-6
13
- -
- -
- -
-1
- -
- -
- -
1
-2
- -
18
12
63
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
19.05
19.52
- -
- -
- -
- -
12.95
45.66
48.71
Effective Tax Rate (%)
-63.58
-14.86
-34.3
202.09
10.09
134.53
- -
- -
- -
- -
-22.31
85.21
- -
-20.33
8.76
1.09
5.1
Profit Margin (%)
-8
3
-22
1
- -
- -
- -
- -
1
1
1
1
-4
2
666
2,837
- -
Working Capital
23
23
20
- -
- -
- -
- -
1
2
2
2
2
- -
6
13
375
- -
LT Debt
-5
-8
-13
- -
- -
- -
- -
-1
-1
-1
-1
- -
-2
-3
811
3,379
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
1.35
3.82
- -
- -
- -
- -
3.51
0.36
- -
Return on Invested Capital (%)
- -
- -
- -
- -
10.24
-32.36
- -
- -
-1.69
-14.52
- -
- -
- -
- -
6.7
1.39
1.48
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2.04
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'25
Jun'26
ST Debt
- -
479
- -
LT Borrowings
- -
3
- -
LT Finance Leases
- -
177
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
64
- -
Market Capitalization
38,855
49,538
47,535

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'25
Jun'26
Total Current Assets
- -
3,653
- -
Cash, Cash Equivalents & STI
- -
2,514
- -
Accounts Receivable, Net
- -
761
- -
Inventories
- -
92
- -
Total Current Liabilities
- -
816
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
479
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-3,640.57%
-7,573.44%
316.53%
Free Cash Flow
675.88%
1,191.98%
1,076.98%
Net Income, GAAP
-689.01%
-1,192.41%
-34.28%
Sales/Revenue/Turnover
- -
- -
427.61%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
208
210
2025
101
397
117
492
1,107
2026
234
1,011
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
-0.53
- -
1.65
2025
- -
0.01
-0.01
- -
0.01
2026
- -
0.3
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
RSC International Limited (RSCINT.BO)
5N Plus Inc. (FPLSF)
Kawaguchi Chemical Industry Co., Ltd (4361.T)
Luxi Chemical Group Co., Ltd. (000830.SZ)
Jubilant Agri and Consumer Products Ltd. (JUBLCPL.NS)
CropEnergies AG (CE2.DE)
Business
Fischer Medical Ventures Limited (formerly Fischer Chemic Limited), headquartered in Chennai, India, and incorporated in 1993, engages in the trading and distribution of medical equipment and diagnostic imaging technologies; core offerings include MRI and CT scanners, medical ultrasound equipment, scientific, medical, and surgical instruments, laboratory grade chemicals, as well as point-of-care diagnostic solutions and AI-powered healthcare innovations manufactured at its facility in Andhra Pradesh MedTech Zone. The company operates primarily in India with international reach through strategic partnerships and targets healthcare providers, hospitals, and diagnostic centers globally. In March 2024, it changed its name from Fischer Chemic Limited to Fischer Medical Ventures Limited to reflect its pivot toward medtech; recent developments include the acquisition of Time Medical International Ventures (India) Private Limited via share swap in early 2024 to enter medical diagnostic imaging, the launch of wholly-owned subsidiary Flynncare Health Innovations Private Limited in July 2024 focused on health technology software and applications, multiple strategic partnerships such as with Nanyang Biologics for nutraceuticals in July 2024, Tech Avant-Garde for educational health programs, Nervotec, Blusim Tech Pte, and Therapy Platform in mid-2024, and an investment in Time Medical Philippines by its unit in July 2024.